What is new in Rome IV

Journal of Neurogastroenterology and Motility

Volumn 23, Issue 2, 2017, Pages 151-163

  Schmulson, Max J ^a   Drossman, Douglas A ^b,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Drossman Center for the Education and Practice of Biopsychosocial Care   (United States)

Author keywords

Constipation; Diarrhea; Functional gastrointestinal disorders; Irritable bowel syndrome; Rome IV

Indexed keywords

ABDOMINAL PAIN; ANORECTAL DISEASE; CLINICAL DECISION MAKING; CONSTIPATION; DEFECATION HABIT; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE CLASSIFICATION; ENTEROPATHY; ESOPHAGUS DISEASE; EVIDENCE BASED PRACTICE; GALLBLADDER; GALLBLADDER DISEASE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL PAIN; HEALTH CARE SURVEY; HUMAN; HYPERSENSITIVITY; IRRITABLE COLON; ITALY; ODDI SPHINCTER; PRIMARY MEDICAL CARE; REVIEW; SMALL INTESTINE DISEASE;

EID: 85016998063     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm16214     Document Type: Review

References (80)

1. Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989:92-95
2. Drossman DA. History of functional gastrointestinal symptoms and disorders and chronicle of the Rome Foundation. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders: disorders of gut-brain interaction. Volume I. Raleigh, NC: The Rome Foundation 2016:549-576
3. Drossman DA, Thompson WG, Talley NJ, Funch-Jeasen P, Janssens J. Identification of subgroups of functional bowel disorders. Gastroenterol Int 1990;3:159-172
4. Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disorders and chronic functional abdominal pain. Gastroenterol Int 1992;5:75-91
5. Talley NJ, ColinJones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145-160
6. Richter JE, Baldi F, Clouse RE, Diamant NE, Janssens J, Staiano A. Functional oesophageal disorders. Gastroenterol Int 1992;5:3-17
7. Whitehead WE, Devroede G, Habib FI, Meunier P, Wald A. Functional disorders of the anorectum. Gastroenterol Int 1992;5:92-108
8. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580
9. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE. The functional gastrointestinal disorders: diagnosis, pathophysiology and treatment. McLean, VA: Degnon Associates 1994
10. Thompson WG. The road to rome. Gastroenterology 2006;130:1552-1556
11. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016;150:1257-1261
12. Drossman DA, Chang L, Chey WD, Kellow J, Tack J, Whitehead WE, The Rome IV Committees. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume I. Raleigh, NC: The Rome Foundation 2016
13. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 2016;150:1262-1279
14. Marciani L, Cox EF, Hoad CL, et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology 2010;138:469-477.e1
15. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702
16. Barau E, Dupont C. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1990;11:72-77
17. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52
18. van Wijk HJ, Smout AJ, Akkermans LM, Roelofs JM, ten Thije OJ. Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome. Scand J Gastroenterol 1992;27:99-102
19. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-406
20. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 2000;355:1035-1040
21. Kellow J, Lee OY, Chang FY, et al. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 2003;52:671-676
22. Van Outryve M, Milo R, Toussaint J, Van Eeghem P. "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebocontrolled study of cisapride. J Clin Gastroenterol 1991;13:49-57
23. Sperber AD, Francisconi C, Fukudo S, et al. Multicultural aspects of functional gastrointestinal disorders. In: Drossman DA, Chang LC, Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume I. Raleigh, NC: The Rome Foundation 2016
24. Schmulson M, Corazziari E, Ghoshal UC, et al. A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: A report of the Rome Foundation Working Team on cross-cultural, multinational research. Neurogastroenterol Motil 2014:26;1368-1385
25. Sperber AD, Gwee KA, Hungin AP, et al. Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report. Aliment Pharmcol Ther 2014;40:1094-1102
26. Whorwell P, Zarzar K. Conducting multinational, cross-cultural research in the functional GI disorders and fostering multinational research networks. Rome Foundation Working Team 2014. Available from URL: http://theromefoundation.org/wp-content/uploads/WorkingTeamFinal-Report_Jan-2014-1.pdf (accessed 8 March, 2017)
27. Francisconi CF, Sperber A, Fang X, et al. Multicultural aspects in functional gastrointestinal disorders (FGIDs). Gastroenterology 2016;150:1344-1354
28. Ballard R. Race, culture and ethnicity. In: Holborn M, ed. New developments in sociology. Ormskirk: The Causeway Press 2002
29. Eisenberg L. Disease and illness. Distinctions between professional and popular ideas of sickness. Cult Med Psychiatry 1977;1:9-23
30. Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol 2009;24:1601-1607
31. Heitkemper MA, Houghton LA, Crowell MD, et al. Age, gender, and women's health and the patient. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume I. Raleigh, NC: The Rome Foundation 2016:307-371
32. Quigley EM, Barbara G, Feinle-Bisset C, et al. The intestinal microenvironment an functional gastrointestinl disorders. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume I. Raleigh, NC: The Rome Foundation 2016:179-247
33. Barbara G, Feinle-Bisset C, Ghoshal UC, et al. The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology 2016:150;1305-1318.e8
34. Levy RL, Crowell MD, Drossman DA, et al. Byopsychosocial aspects of functional gastrointestinl disorders: How central and environmental processes contribute to the development and expression of FGIDs. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume I. Raleigh, NC: The Rome Foundation 2016:443-548
35. Whorwell PJ, Keefer L, Drossman DA, Guthrie E, Simrén M, Tillisch K, Olden K. Centrally mediated disorders of gastrointestinal pain. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume II. Raleigh, NC: The Rome Foundation 2016:1059-1116
36. Keefer L, Drossman DA, Guthrie E, et al. Centrally mediated disorders of gastrointestinal pain. Gastroenterology 2016:150;1408-1419
37. Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology 2016:150;1393-1407, e5
38. Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology 2016;150:1380-1392
39. Palsson OS, Whitehead WE, van Tilburg MA, et al. Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology 2016;150:1481-1491
40. Whitehead EE, Palsson OS, M.A.L. vT, Sperber A, B. S, Tack J, Walker LS, Y. Y. Development and validation of the Rome IV diagnostic questionnaires. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Raleigh, NC: The Rome Foundation 2016:43-92
41. Schmulson M, Adeyemo M, Gutiérrez-Reyes G, et al. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-932
42. Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut 2015;64:1049-1057
43. Galmiche JP, Clouse RE, Bálint A, et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-1465
44. Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis2011;43:542-547
45. Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional esophageal disorders. Gastroenterology 2016:150;1368-1379
46. Bisschops R, Karamanolis G, Arts J,. Relationship between symptoms and ingestion of a meal in functional dyspepsia. Gut 2008;57:1495-1503
47. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479
48. Talley NJ, Stanghellini V, Chan FKL, et al. Gastroduodenal Disorders. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume II. Raleigh, NC: The Rome Foundation 2016:903-965
49. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simrén M, Spiller R. Bowel Disorders. In: Drossman DA, Chang LC, W Kellow J, Tack J, Whitehead WE, The Rome IV Committees, eds. Rome IV functional gastrointestinal disorders-disorders of gut-brain interaction. Volume II. Raleigh, NC: The Rome Foundation 2016:967-1057
50. Sperber AD, Dumitrascu D, Fukudo S, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut Published Online First: 13 Feb 2016. doi: 10.1053/j.gastro.2016.02.014
51. Spiegel BM, Bolus R, Agarwal N, et al. Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. Aliment Pharmacol Ther 2010;32:1275-1291
52. Hellstrom PM, Saito YA, Bytzer P, Tack J, Mueller-Lissner S, Chang L. Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria. Am J Gastroenterol 2011;106:1299-1307
53. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491
54. Palson O, van Tilburg M, Simren M, Sperber AD, Whithead W. Mo1642 population prevalence of Rome IV and Rome III irritable bowel syndrome (IBS) in the United States (US), Canada and the United Kingdom (UK). Gastroenterology 2016;150:S739-S740
55. Ghoshal UC, Gwee KA, Chen M, et al. Development, translation and validation of enhanced asian Rome III questionnaires for diagnosis of functional bowel diseases in major asian languages: a Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report. J Neurogastroenterol Motil 2015;21:83-92
56. Morgan D, Martin C, Pena E, et al. Significant differences in Rome II and Rome III determination of FGID prevalence: Population-based assessments in Central America. Gastroenterology 2012;142(suppl 1):S573
57. Schmulson M, Lopez-Colombo A, Mendoza-Gomez A, Montiel-Jarquin A, Morgan D. Tu1426 The Rome III adult questionnaire in Spanish-Mexico has a low sensitivity for identifying IBS and higher sensitivity for uninvestigated dyspepsia. Gastroenterology 2012;142:S829
58. Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005;128:580-589
59. Lewis MJ, Reilly B, Houghton LA, Whorwell PJ. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut 2001;48:216-220
60. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-380
61. Jamal MM, Adams AB, Jansen JP, Webster LR. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain. Am J Gastroenterol2015;110:725-732
62. Argoff CE, Brennan MJ, Camilleri M, et al. Consensus recommendations on initiating prescription therapies for opioid-Induced constipation. Pain Med 2015;16:2324-2337
63. Drossman DA. 2012 David Sun lecture: helping your patient by helping yourself-how to improve the patient-physician relationship by optimizing communication skills. Am J Gastroentetol 2013;108:521-528
64. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006;354:1243-1252
65. Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol 2007;5:1126-1139
66. Drossman DA, Morris CB, Edwards H, et al. Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome. Am J Gastroenterol 2012;107:1426-1440
67. Cotton PB, Elta GH, Carter CR, Pasricha PJ, Corazziari ES. Rome IV. Gallbladder and sphincter of oddi disorders. Gastroenterology 2016:150;1420-1429.e2
68. Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on painrelated disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA 2014;311:2101-2109
69. Toouli J, Roberts-Thomson IC, Kellow J, Dowsett J, Saccone GT, Evans P, Jeans P, Cox M, Anderson P, Worthley C, Chan Y, Shanks N, Craig A. Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 2000;46:98-102
70. Rao SS, Bharucha AE, Chiarioni G, et al. Anorectal disorders. Gastroenterology 2016:150;1430-1442.e4
71. Prott G, Shim L, Hansen R, Kellow J, Malcolm A. Relationships between pelvic floor symptoms and function in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:764-769
72. Grossi U, Carrington EV, Bharucha AE, Horrocks EJ, Scott SM, Knowles CH. Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. Gut 2016;65:447-455
73. Rao SS, Mudipalli RS, Stessman M, Zimmerman B. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil 2004;16:589-596
74. Ratuapli SK, Bharucha AE, Noelting J, Harvey DM, Zinsmeister AR. Phenotypic identification and classification of functional defecatory disorders using high-resolution anorectal manometry. Gastroenterology 2013;144:314-322 e2
75. Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology 2016:150;1443-1455.e2
76. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology 2016:150;1456-1468.e2
77. Kellow J, Guest Ed, Drossman DA, et al. Rome IV diagnostic algorithms for common GI symptoms. 2nd ed. Raleigh, NC: The Rome Foundation 2016
78. Drossman DA, Guest Ed, Azpiroz F, et al. Multi-dimensional clinical profile (MDCP) for the functional gastrointestinal disorders. 1st ed. Raleigh, NC: The Rome Foundation 2015
79. Drossman DA, Senior Ed, Chang L, et al. Rome IV multidimensional clinical profile for the functional gastrointestinal disorders. 2nd ed. Raleigh, NC: The Rome Foundation 2016
80. Heidelbaugh J, Hungin P, Guest Eds, and The Rome IV Primary Care Committee, Drossman DA, Chang L, Kellow J, Chey WD, Tack J, Whitehead WE, Eds. Rome IV functional gastrointestinal disorders for primary care and non-GI clinicians. 1st ed. Raleigh, NC: The Rome Foundation 2016